SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Kevin Clarke who wrote (4073)9/19/1998 12:55:00 AM
From: Profiteer  Respond to of 5402
 
Kevin, Dr. Drees did not sell off any rights of the 1st generation PHER-02 and has patents pending in place through the 2nd generation. The important thing to remember that we are now in 2nd generation testing stages.. much further along then any other substitute product.

If you go to the SGNC Information thread: Subject 21537
the entire story is cover and will be of great help to you understanding this stock.
Glad to see you aboard...



To: Kevin Clarke who wrote (4073)9/19/1998 1:19:00 AM
From: Profiteer  Read Replies (2) | Respond to of 5402
 
Kevin, one other suggestion. Look over RG's SGNC Homepage at: members.aol.com

You will find more useful information there.